The syntheses and characterization of a number of palladium complexes containing imine and/or iminoacyl groups are reported. Our strategies toward the insertion of imines into palladium iminoacyl complexes are outlined. The imine complexes [Pd(Me)(L 2 ){N(R′)═C(H)Ph}]X (where L 2 = dppe, dppp, dppf; R′ = Ph, Me, Bz; and X = BF 4 or OTf) were prepared and fully characterized. [Pd(Me)(dppe){N(Ph)═C(H)Ph}]BF 4 ( 1 ) and [Pd(Me)(dppp){N(Ph)═C(H)Ph}]OTf ( 4 ) were structurally characterized by X-ray crystallography. The iminoacyl-imine complexes [Pd{C(Me)═NXyl} (L 2 ){ N═C(Me)OCH 2 CH 2 }]BF 4 (L 2 = dppe, 12; dppp, 13 ) were prepared. The bis-imine complex [Pd(dppe){ N═C(Me)OCH 2 CH 2 } 2 ][BF 4 ] 2 ( 14 ) resulting from disproportionation of 12 was also prepared and structurally characterized. Protonation of the iminoacyl fragment provided iminoacyl imine complex [Pd{C(CH 3 )═N(H)Xyl}(dppe){N(Bz)═CPhH}][BF 4 ] 2 ( 17 ), which was sufficiently stable to be structurally characterized, providing some insight into the coordination of these fragments to palladium.
No takes yet. Share an insight, caveat, or question.
Owen et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: